Prot# ML18124: A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety & Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys®) + Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C

  • Kulik, Laura M (PD/PI)
  • Abecassis, Michael Messod (Co-PD/PI)
  • Baker, Talia Barzel (Co-PD/PI)
  • Fryer, Jonathan Paul (Co-PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/4/05 → 11/1/11

Funding

  • Roche Laboratories Inc. (ML18124)